SanBio Company Income Statement

Financials in millions JPY. Fiscal year is February - January.

Millions JPY. Fiscal year is Feb - Jan.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021	2016 - 2020
Selling, General & Admin	1,159	1,690	1,781	1,665	1,730	Upgrade
Research & Development	2,357	2,849	6,118	4,955	4,071	Upgrade
Operating Expenses	3,516	4,539	7,899	6,620	5,801	Upgrade
Operating Income	-3,516	-4,539	-7,899	-6,620	-5,801	Upgrade
Interest Expense	-8	-10	-26	-44	-48	Upgrade
Interest & Investment Income	2	2	4	5	8	Upgrade
Currency Exchange Gain (Loss)	622	1,746	3,326	1,961	-634	Upgrade
Other Non Operating Income (Expenses)	-120	-23	-103	119	-54	Upgrade
EBT Excluding Unusual Items	-3,020	-2,824	-4,698	-4,579	-6,529	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	3,318	Upgrade
Gain (Loss) on Sale of Assets	2	33	1	-	-	Upgrade
Asset Writedown	-	-3	-	-10	-	Upgrade
Other Unusual Items	9	252	-	29	-	Upgrade
Pretax Income	-3,009	-2,542	-4,697	-4,560	-3,211	Upgrade
Income Tax Expense	-127	102	862	117	174	Upgrade
Net Income	-2,882	-2,644	-5,559	-4,677	-3,385	Upgrade
Net Income to Common	-2,882	-2,644	-5,559	-4,677	-3,385	Upgrade
Shares Outstanding (Basic)	69	65	58	52	52	Upgrade
Shares Outstanding (Diluted)	69	65	58	52	52	Upgrade
Shares Change (YoY)	5.42%	12.78%	11.83%	0.01%	1.31%	Upgrade
EPS (Basic)	-41.85	-40.48	-95.98	-90.31	-65.37	Upgrade
EPS (Diluted)	-41.85	-40.48	-95.98	-90.31	-65.37	Upgrade
Free Cash Flow	-3,607	-4,776	-7,441	-6,588	-5,311	Upgrade
Free Cash Flow Per Share	-52.38	-73.11	-128.47	-127.21	-102.56	Upgrade
EBITDA	-3,507	-4,525	-7,875	-6,488	-5,727	Upgrade
D&A For EBITDA	9	14	24	132	74	Upgrade
EBIT	-3,516	-4,539	-7,899	-6,620	-5,801	Upgrade

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.